Advertisement

Topics

FDA announces voluntary recall of several medicines containing valsartan following detection of an impurity

13:35 EDT 13 Jul 2018 | FDA

FDA is alerting the public about a voluntary recall of several drug products containing valsartan, used to treat high blood pressure and heart failure

Original Article: FDA announces voluntary recall of several medicines containing valsartan following detection of an impurity

NEXT ARTICLE

More From BioPortfolio on "FDA announces voluntary recall of several medicines containing valsartan following detection of an impurity"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...